This is the first article of our series, “The ATMP Manufacturer’s Guide to Commercialisation and cGMP Compliance”. The shift from R&D to the regulated cGMP facility is often a difficult gap to bridge, ...
Umoja Biopharma, Inc., a clinical-stage biotechnology company, sees a different future for oncology and autoimmunity treatment—a future that provides improved patient access and alleviates the burdens ...
This is the second part of our series, "The ATMP Manufacturer's Guide to Commercialisation and cGMP Compliance". The first article in the ATMP series focused on the standardised production platform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results